Literature DB >> 18070757

Role of adiponectin and inflammation in insulin resistance of Mc3r and Mc4r knockout mice.

James L Trevaskis1, Barbara Gawronska-Kozak, Gregory M Sutton, Michele McNeil, Jacqueline M Stephens, Steven R Smith, Andrew A Butler.   

Abstract

OBJECTIVE: To investigate the involvement of hypoadiponectinemia and inflammation in coupling obesity to insulin resistance in melanocortin-3 receptor and melanocortin-4 receptor knockout (KO) mice (Mc3/4rKO). RESEARCH METHODS AND PROCEDURES: Sera and tissue were collected from 6-month-old Mc3rKO, Mc4rKO, and wild-type C57BL6J litter mates maintained on low-fat diet or exposed to high-fat diet (HFD) for 1 or 3 months. Inflammation was assessed by both real-time polymerase chain reaction analysis of macrophage-specific gene expression and immunohistochemistry.
RESULTS: Mc4rKO exhibited hypoadiponectinemia, exacerbated by HFD and obesity, previously reported in murine models of obesity. Mc4r deficiency was also associated with high levels of macrophage infiltration of adipose tissue, again exacerbated by HFD. In contrast, Mc3rKO exhibited normal serum adiponectin levels, irrespective of diet or obesity, and a delayed inflammatory response to HFD relative to Mc4rKO. DISCUSSION: Our findings suggest that severe insulin resistance of Mc4rKO fed a HFD, as reported in other models of obesity such as leptin-deficient (Lep(ob)/Lep(ob)) and KK-A(y) mice, is linked to reduced serum adiponectin and high levels of inflammation in adipose tissue. Conversely, maintenance of normal serum adiponectin may be a factor in the relatively mild insulin-resistant phenotype of severely obese Mc3rKO. Mc3rKO are, thus, a unique mouse model where obesity is not associated with reduced serum adiponectin levels. A delay in macrophage infiltration of adipose tissue of Mc3rKO during exposure to HFD may also be a factor contributing to the mild insulin resistance in this model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18070757      PMCID: PMC2753182          DOI: 10.1038/oby.2007.318

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  40 in total

Review 1.  Anatomy and regulation of the central melanocortin system.

Authors:  Roger D Cone
Journal:  Nat Neurosci       Date:  2005-05       Impact factor: 24.884

2.  Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

Authors:  D Huszar; C A Lynch; V Fairchild-Huntress; J H Dunmore; Q Fang; L R Berkemeier; W Gu; R A Kesterson; B A Boston; R D Cone; F J Smith; L A Campfield; P Burn; F Lee
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

3.  Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance.

Authors:  C Weyer; J E Foley; C Bogardus; P A Tataranni; R E Pratley
Journal:  Diabetologia       Date:  2000-12       Impact factor: 10.122

4.  Increased oxidative stress in obesity and its impact on metabolic syndrome.

Authors:  Shigetada Furukawa; Takuya Fujita; Michio Shimabukuro; Masanori Iwaki; Yukio Yamada; Yoshimitsu Nakajima; Osamu Nakayama; Makoto Makishima; Morihiro Matsuda; Iichiro Shimomura
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

5.  Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone.

Authors:  Gina B Di Gregorio; Aiwei Yao-Borengasser; Neda Rasouli; Vijayalakshmi Varma; Tong Lu; Leslie M Miles; Gouri Ranganathan; Charlotte A Peterson; Robert E McGehee; Philip A Kern
Journal:  Diabetes       Date:  2005-08       Impact factor: 9.461

6.  Mitochondrial dysfunction and type 2 diabetes.

Authors:  Bradford B Lowell; Gerald I Shulman
Journal:  Science       Date:  2005-01-21       Impact factor: 47.728

7.  Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass.

Authors:  A S Chen; D J Marsh; M E Trumbauer; E G Frazier; X M Guan; H Yu; C I Rosenblum; A Vongs; Y Feng; L Cao; J M Metzger; A M Strack; R E Camacho; T N Mellin; C N Nunes; W Min; J Fisher; S Gopal-Truter; D E MacIntyre; H Y Chen; L H Van der Ploeg
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

8.  Increasing prevalence of the metabolic syndrome among u.s. Adults.

Authors:  Earl S Ford; Wayne H Giles; Ali H Mokdad
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

9.  Life without white fat: a transgenic mouse.

Authors:  J Moitra; M M Mason; M Olive; D Krylov; O Gavrilova; B Marcus-Samuels; L Feigenbaum; E Lee; T Aoyama; M Eckhaus; M L Reitman; C Vinson
Journal:  Genes Dev       Date:  1998-10-15       Impact factor: 11.361

10.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

View more
  22 in total

Review 1.  Homeostastic and non-homeostatic functions of melanocortin-3 receptors in the control of energy balance and metabolism.

Authors:  Karima Begriche; Gregory M Sutton; Andrew A Butler
Journal:  Physiol Behav       Date:  2011-04-13

Review 2.  Mouse models of the metabolic syndrome.

Authors:  Arion J Kennedy; Kate L J Ellacott; Victoria L King; Alyssa H Hasty
Journal:  Dis Model Mech       Date:  2010 Mar-Apr       Impact factor: 5.758

Review 3.  Unravelling the mysterious roles of melanocortin-3 receptors in metabolic homeostasis and obesity using mouse genetics.

Authors:  C Girardet; K Begriche; A Ptitsyn; R A Koza; A A Butler
Journal:  Int J Obes Suppl       Date:  2014-07-08

4.  Sexual dimorphism in obesity-related genes in the epicardial fat during aging.

Authors:  Caitlin Kocher; Matthew Christiansen; Sarah Martin; Christopher Adams; Paulette Wehner; Todd Gress; Nalini Santanam
Journal:  J Physiol Biochem       Date:  2016-12-24       Impact factor: 4.158

5.  Olfactory ability and object memory in three mouse models of varying body weight, metabolic hormones, and adiposity.

Authors:  Kristal R Tucker; Steven J Godbey; Nicolas Thiebaud; Debra Ann Fadool
Journal:  Physiol Behav       Date:  2012-09-17

6.  The melanocortin MC(1) receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature.

Authors:  G Leoni; M-B Voisin; K Carlson; Sj Getting; S Nourshargh; M Perretti
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

Review 7.  Physiological roles of the melanocortin MC₃ receptor.

Authors:  Benjamin J Renquist; Rachel N Lippert; Julien A Sebag; Kate L J Ellacott; Roger D Cone
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

Review 8.  Melanocortin-3 receptors and metabolic homeostasis.

Authors:  Karima Begriche; Clemencé Girardet; Patricia McDonald; Andrew A Butler
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

Review 9.  The microcirculation in adipose tissue inflammation.

Authors:  Rosario Scalia
Journal:  Rev Endocr Metab Disord       Date:  2013-03       Impact factor: 6.514

Review 10.  Neural melanocortin receptors in obesity and related metabolic disorders.

Authors:  Clemence Girardet; Andrew A Butler
Journal:  Biochim Biophys Acta       Date:  2013-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.